Company Overview
| Stock Name | 3D Medicines |
|---|---|
| Stock Code | 01244 |
| Company Full Name | To be extracted |
| Industry | 醫療保健 |
| Principal Activities | 主要於中國開發及商業化治療腫瘤產品及藥物。 |
| Listing Date | 2022-12-15 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國上海市浦東新區芙蓉花路118號11號樓 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | https://www.3d-medicines.com/ |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 24.98 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 57.4% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 40,842,300 |
Stock Connect Inclusion
| HK Market Cap | --- |
|---|
| 26Q2 Regular Review | |
| Inclusion Pathway | None |
|---|---|
| Est. Threshold | --- |
| Analysis Result | 无法确定入通路径 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 31.45 |
|---|---|
| First Day Open | HK$ 29.0 |
| First Day Change | 25.90% |
| First Day Volume | 1515300.0 |
| First Day Turnover | 44431600.0 |
Use of Proceeds
| Use of Proceeds | 1、約55%，或138.1百萬港元，將用于公司的核心產品恩沃利單抗； 2、約25%，或62.8百萬港元，將用于公司的其他候選藥物； 3、約10%，或25.1百萬港元，將用于建造公司位于江蘇省徐州市的內部生產設施及采購新機器、儀器和設備； 4、約10%，或25.1百萬港元，將用于公司的一般企業及營運資金用途。 |
|---|
Underwriting Syndicate
Joint Sponsors (2)
Overall Coordinators (3)
Joint Bookrunners (8)
China International Capital Corporation Hong Kong Securities Limited CE AEN894
China Securities (International) Corporate Finance Company Limited CE BAU112
CNCB (Hong Kong) Capital Limited CE AEQ982
CCB International Capital Limited CE AJO225
XinKong International Securities Limited CE ACV085
Livermore Holdings Limited CE BJN764
ABCI Securities Company Limited CE ACX411
Tiger Brokers (HK) Global Limited CE BMU940
Joint Lead Managers (13)
China International Capital Corporation Hong Kong Securities Limited CE AEN894
China Securities (International) Corporate Finance Company Limited CE BAU112
CNCB (Hong Kong) Capital Limited CE AEQ982
CCB International Capital Limited CE AJO225
XinKong International Securities Limited CE ACV085
Livermore Holdings Limited CE BJN764
ABCI Securities Company Limited CE ACX411
Tiger Brokers (HK) Global Limited CE BMU940
SDHG International Securities Limited CE ADY241
Lego Securities Limited CE BIE918
VALUABLE CAPITAL LIMITED CE AUL711
Futu Securities International (Hong Kong) Limited CE AZT137
VICTORY SECURITIES COMPANY LIMITED CE ABN091
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Harvest International Premium Value (Secondary Market) Fund SPC | 78,449,690 HKD | — | 19.21% | — | 6 months | 2023-06-15 |
| 2 | Mobilewise Limited | 31,374,880 HKD | — | 7.68% | — | 6 months | 2023-06-15 |
| 3 | 好赞资产管理有限公司 | 78,449,690 HKD | — | 19.21% | — | 6 months | 2023-06-15 |
| 4 | 徐州经济技术开发区(香港)投资有限公司 | 46,325,410 HKD | — | 11.34% | — | 6 months | 2023-06-15 |
Directors & Management
| Chairman | 龔兆龍 |
|---|---|
| Company Secretary | 夏芳;李菁怡 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 龔兆龍(29.08%);上海甄路企業管理諮詢合夥企業(有限合夥)(5.40%) |
|---|
